About Us

Company History

BioSpeedia is a biotechnology company founded by two scientific researchers from Institut Pasteur and is part of an outstanding scientific ecosystem.

  • Founded in 2011

    The establishment of BioSpeedia

    After spending 3 decades at Institut Pasteur, Yves Germani and Evelyne Begaud, establish the Company as the official spin-off from the premier French Institute.

  • 2012

    Grant from AIMA Lab

  • 2012

    Grant from OSEO Crea Dev / BPI

  • 2014

    Grant from Aide au Partenariat Technologique

  • 2017

    Developed fast and accurate lateral flow diagnostic kit to detect Neisseria meningitidis (Menincococcus)

    Developed a diagnostic kit to rapidly detect bacterial meningitis using spinal fluid and subsequently using urine samples.

  • 2018

    WHO approves MeningoSpeed detection kit in spinal fluid

  • 2020

    Received CE Mark for its SARS-Cov-2 rapid antibody test kit

    COVID19SEROSpeed-IgM-IgG Test is an immunochromatographic assay designed for the qualitative detection and differentiation of specific IgM and IgG antibodies to coronavirus 2019-nCoV or SARS-CoV-2 in human fingertip blood samples

  • 2020

    Seal of Excellence from H2020

    For COVID-19 Response